Changes to the website
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4782

Previous 25           Next 25
Website Changes
02/13/2019 Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation
02/13/2019 Progesterone is more effective than dexamethasone in prolonging overall survival and preserving neurologic functions in experimental animals with orthotopic glioblastoma allografts.
02/13/2019 Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema.
02/13/2019 Race influences survival in glioblastoma patients with KPS =?80 and associates with genetic markers of retinoic acid metabolism.
02/13/2019 Oncotelic Reports that It`s Proprietary In-Situ Cancer Vaccine Improved Survival over Standard Chemotherapy in Patients with Recurrent Metastatic Pancreas Cancer and Recurrent High Grade Glioma
02/12/2019 Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
02/12/2019 Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
02/11/2019 Ziopharm Oncology Completes Enrollment of Controlled IL-12 Monotherapy Expansion Substudy in Phase 1 Brain Cancer Trial
02/10/2019 Medicenna Presents Promising Clinical Data from Phase 2b Recurrent Glioblastoma Trial of MDNA55
02/06/2019 Brain Tumor `Pied Piper` Device Gains Breakthrough Status
02/05/2019 Moleculin Biotech (MBRX) Announces FDA Orphan Drug Designation for its Brain Tumor Drug
01/31/2019 GT Medical Technologies Announces Publication of Data Showing Company’s Targeted Therapy is Effective for Treating Recurrences of Common Type of Brain Tumor
01/30/2019 Musella Foundation awards a pediatric brain tumor research grant!
01/26/2019 The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma.
01/26/2019 Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells.
01/26/2019 Early clinical trials of Toca 511 and Toca FC show a promising novel treatment for recurrent malignant glioma.
01/26/2019 Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial
01/26/2019 Effect of health disparities on overall survival of patients with glioblastoma.
01/25/2019 New Liquid Biopsy Test Detects Brain Cancer, But It Doesn`t Use Blood
01/23/2019 Regorafenib Doubles 12-Month Survival Compared with Lomustine in Recurrent GBM
01/22/2019 Dexamethasone—Friend or Foe for Patients With Glioblastoma?
01/19/2019 Activation of dopamine receptor 2 (DRD2) prompts transcriptomic and metabolic plasticity in glioblastoma.
01/18/2019 Optune Open House, Newton, MA
01/14/2019 Copay assistance program is now open!
01/11/2019 Publication Reports Role of Dopamine Receptors in Cancer and ONC201 Response



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740